General European Strategic Investments Inc.
GESI
$0.0104
$0.00032.97%
| Weiss Ratings | GESI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | GESI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GESI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -1.22 | |||
| Price History | GESI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -31.13% | |||
| 30-Day Total Return | 2.97% | |||
| 60-Day Total Return | -50.94% | |||
| 90-Day Total Return | -48.26% | |||
| Year to Date Total Return | -16.80% | |||
| 1-Year Total Return | -68.39% | |||
| 2-Year Total Return | -96.50% | |||
| 3-Year Total Return | -99.75% | |||
| 5-Year Total Return | -99.74% | |||
| 52-Week High % Change | -89.90% | |||
| 52-Week Low % Change | 304.00% | |||
| Price | GESI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.10 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | May 21, 2024 | |||
| 52-Week High Price (Date) | Nov 11, 2024 | |||
| Valuation | GESI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.47M | |||
| Enterprise Value | -13.85M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -58.82% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.07 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | 50.18 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GESI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 343.95M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GESI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 702-983-1256 | |||
| Address | 6605 Grand Montecito Parkway Las Vegas, NV 89149 | |||
| Website | generaleuropeanstrategicinvestments.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | GESI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | GESI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | GESI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 29.15% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | -150.00% | |||
| Balance Sheet | GESI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 122.20K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | 24.73M | |||
| Current Ratio (Q) | 0.071 | |||
| Book Value Per Share (Q) | $0.14 | |||
| Total Assets (Q) | 33.92M | |||
| Total Current Liabilities (Q) | 1.73M | |||
| Total Debt (Q) | 7.64M | |||
| Total Liabilities (Q) | 9.19M | |||
| Total Common Equity (Q) | 49.69M | |||
| Cash Flow | GESI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
